Skip to main content

Botulinum Toxin A: Treatment Principles

  • Chapter
  • First Online:
Non-Surgical Rejuvenation of Asian Faces
  • 1433 Accesses

Abstract

Botulinum toxin injections are effective for various therapeutic purposes (e.g., managing movement disorders such as dystonia and spasticity). Efficacy and safety of botulinum toxin type A have been proven effective for cosmetic purposes, including wrinkle reduction, some skin concerns, contouring of the face, and rejuvenation purposes. The use of botulinum toxin type A for facial rejuvenation is the most popular non-surgical cosmetic treatment carried out internationally. Various factors affect the efficacy of treatment, including individual anatomy, practitioners’ knowledge and expertise, injection location and target area, dosage, volume, and injection technique. In this chapter, the main influencing factors and considerations (i.e., dosage, injection size/depth, and synergistic/antagonist muscles) are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lowe NJ, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow’s feet. Dermatol Surg. 2005;31(3):257–62.

    Article  CAS  Google Scholar 

  2. Rivers JK, et al. Subject satisfaction with onabotulinumtoxin A treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure. Dermatol Surg. 2015;41(8):950–9.

    Article  CAS  Google Scholar 

  3. Carruthers J, Carruthers A. Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg. 2007;33:S10–7.

    Article  CAS  Google Scholar 

  4. Beer KR. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids. Dermatol Surg. 2006;32(2):184–92.

    CAS  PubMed  Google Scholar 

  5. Chang BL, et al. Patient perceived benefit in facial aesthetic procedures: FACE-Q as a tool to study botulinum toxin injection outcomes. Aesthet Surg J. 2016;36(7):810–20.

    Article  Google Scholar 

  6. Kowalski J, et al. Initial development of a patient-completed questionnaire to assess outcomes of aesthetic treatment for hyperfunctional facial lines of the upper face. In Poster presented at the American Academy of Dermatology Academy’s ’05 Annual Meeting, Chicago, IL. 2005.

    Google Scholar 

  7. Cox SE, et al. Development of the facial lines treatment satisfaction questionnaire and initial results for botulinum toxin type A–treated patients. Dermatol Surg. 2003;29(5):444–9.

    Article  Google Scholar 

  8. Hexsel D, et al. Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial. JAMA Dermatol. 2013;149(12):1386–91.

    Article  CAS  Google Scholar 

  9. Hexsel D, et al. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial. J Am Acad Dermatol. 2012;67(2):226–32.

    Article  CAS  Google Scholar 

  10. Alimohammadi M, Andersson M, Punga AR. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study. Acta Derm Venereol. 2014;94(1):32–7.

    Article  Google Scholar 

  11. Kim H, et al. A study on glabellar wrinkle patterns in Koreans. J Eur Acad Dermatol Venereol. 2014;28(10):1332–9.

    Article  CAS  Google Scholar 

  12. Ramirez-Castaneda J, et al. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013;28(13):1775–83.

    Article  CAS  Google Scholar 

  13. Hsu TS, Dover JS, Arndt KA. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol. 2004;140(11):1351–4.

    Article  CAS  Google Scholar 

  14. Wu WT. Microbotox of the lower face and neck: evolution of a personal technique and its clinical effects. Plast Reconstr Surg. 2015;136(5):92S–100S.

    Article  CAS  Google Scholar 

  15. Cao Y, et al. A comparative in vivo study on three treatment approaches to applying topical botulinum toxin A for crow’s feet. Biomed Res Int. 2018;2018:6235742.

    PubMed  PubMed Central  Google Scholar 

  16. Jiang HY, et al. Diffusion of two botulinum toxins type A on the forehead: double-blinded, randomized, controlled study. Dermatol Surg. 2014;40(2):184–92.

    Article  CAS  Google Scholar 

  17. Elwischger K, et al. Intramuscular distribution of botulinum toxin--visualized by MRI. J Neurol Sci. 2014;344(1–2):76–9.

    Article  CAS  Google Scholar 

  18. Gosain AK, et al. A volumetric analysis of soft-tissue changes in the aging midface using high-resolution MRI: implications for facial rejuvenation. Plast Reconstr Surg. 2005;115(4):1143–52; discussion 1153–5.

    Article  CAS  Google Scholar 

  19. Cohen S, Artzi O, Heller L. Forehead lift using botulinum toxin. Aesthet Surg J. 2018;38(3):312–20.

    Article  Google Scholar 

  20. Mustak H, et al. Use of botulinum toxin for the correction of mild ptosis. J Clin Aesthet Dermatol. 2018;11(4):49–51.

    PubMed  PubMed Central  Google Scholar 

  21. Jay GW, Barkin RL. Primary Headache disorders-part 2: tension-type headache and medication overuse headache. Dis Mon. 2017;63(12):342–67.

    Article  Google Scholar 

  22. Belvís R, Mas N. Treatment of chronic migraine with intramuscular pericranial injections of onabotulinumtoxin A. Recent Pat CNS Drug Discov. 2014;9(3):181–92.

    Article  Google Scholar 

  23. Rzany B, et al. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg. 2007;33:S18–25.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Han, X., Samizadeh, S. (2022). Botulinum Toxin A: Treatment Principles. In: Samizadeh, S. (eds) Non-Surgical Rejuvenation of Asian Faces. Springer, Cham. https://doi.org/10.1007/978-3-030-84099-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-84099-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-84098-3

  • Online ISBN: 978-3-030-84099-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics